Patient Portal / Log In


MAKE AN APPOINTMENT > Our Hemophilia Treatment Center is designated a Center of Excellence by the State of Washington

The WACBD is staffed by several internationally recognized researchers and conducts numerous clinical and translational studies. Many of these studies are enabled, enhanced and safeguarded by a strong collaborative relationship with the Research Institute at Bloodworks Northwest.

WACBD is participating in Community Counts

Community Counts is a public health monitoring program funded by CDC’s Division of Blood Disorders. The purpose of this project is to gather and share information about common health issues, medical complications, and causes of death that affect people with bleeding disorders cared for in U.S. Hemophilia Treatment Centers (HTCs).

Some other clinical studies WACBD is conducting include:
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

Handheld Ultrasound (HHUS) for Home Use in Hemophilia A

Von Willebrand Factor in Pregnancy (VIP) Study

Minimize Menorrhagia in Women With Von Willebrand Disease

Other clinical trials investigating gene therapy and other treatments for bleeding disorders are ongoing. Make sure you ask us during your visit about potential studies you might be eligible for when you come and visit us.